» Articles » PMID: 33669554

Fetal Cardiac Interventions-Are They Safe for the Mothers?

Overview
Journal J Clin Med
Specialty General Medicine
Date 2021 Mar 6
PMID 33669554
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of fetal cardiac interventions (FCI), as other prenatal therapeutic procedures, is to bring benefit to the fetus. However, the safety of the mother is of utmost importance. The objective of our study was to evaluate the impact of FCI on maternal condition, course of pregnancy, and delivery. 113 mothers underwent intrauterine treatment of their fetuses with critical heart defects. 128 percutaneous ultrasound-guided FCI were performed and analyzed. The patients were divided into four groups according to the type of FCI: balloon aortic valvuloplasty (fBAV), balloon pulmonary valvuloplasty (fBPV), interatrial stent placement (IAS), and balloon atrioseptoplasty (BAS). Various factors: maternal parameters, perioperative data, and pregnancy complications, were analyzed. There was only one major complication-procedure-related placental abruption (without need for blood products transfusion). There were no cases of: procedure-related preterm prelabor rupture of membranes (pPROM), chorioamnionitis, wound infection, and anesthesia associated complications. Tocolysis was only necessary only in two cases, and it was effective in both. None of the patients required intensive care unit admission. The procedure was effective in treating polyhydramnios associated with fetal heart failure in six out of nine cases. Deliveries occurred at term in 89%, 54% were vaginal. The results showed that FCI had a negligible impact on a further course of pregnancy and delivery.

Citing Articles

Impact of fetal pulmonary valvuloplasty in in-utero critical pulmonary stenosis: A systematic review and meta-analysis.

Mendel B, Kohar K, Yumnanisha D, Djiu R, Winarta J, Prakoso R Int J Cardiol Congenit Heart Dis. 2024; 15:100485.

PMID: 39713496 PMC: 11657412. DOI: 10.1016/j.ijcchd.2023.100485.


Balloon Aortic Valvuloplasty in the Modern Era: A Review of Outcomes, Indications, and Technical Advances.

Zhong J, Kamp N, Bansal A, Kumar A, Puri R, Krishnaswamy A J Soc Cardiovasc Angiogr Interv. 2024; 2(4):101002.

PMID: 39131636 PMC: 11307741. DOI: 10.1016/j.jscai.2023.101002.


Beyond Technical Success of Fetal Aortic Valvuloplasty.

Freud L JACC Adv. 2024; 3(3):100836.

PMID: 38938831 PMC: 11198671. DOI: 10.1016/j.jacadv.2024.100836.


Catheter-Based Fetal Cardiac Interventions.

Yilmaz Furtun B, Morris S J Cardiovasc Dev Dis. 2024; 11(6).

PMID: 38921667 PMC: 11204342. DOI: 10.3390/jcdd11060167.


Prognosis and outcome of intrauterine treatment of fetuses with critical congenital heart disease.

Zhao L, Wang L, Xia H, Wu Y, Jiao X, Zhu H Chin Med J (Engl). 2023; 137(12):1431-1436.

PMID: 37488672 PMC: 11188866. DOI: 10.1097/CM9.0000000000002796.


References
1.
Van de Velde M, De Buck F . Fetal and maternal analgesia/anesthesia for fetal procedures. Fetal Diagn Ther. 2012; 31(4):201-9. DOI: 10.1159/000338146. View

2.
Vida V, Bacha E, Larrazabal A, Gauvreau K, Thiagaragan R, Fynn-Thompson F . Hypoplastic left heart syndrome with intact or highly restrictive atrial septum: surgical experience from a single center. Ann Thorac Surg. 2007; 84(2):581-5. DOI: 10.1016/j.athoracsur.2007.04.017. View

3.
Debska M, Kolesnik A, Rebizant B, Sekowska A, Grzyb A, Chaberek K . Fetal Cardiac Interventions-Polish Experience from "Zero" to the Third World Largest Program. J Clin Med. 2020; 9(9). PMC: 7576494. DOI: 10.3390/jcm9092888. View

4.
Mayhew D, Mendonca V, Murthy B . A review of ASA physical status - historical perspectives and modern developments. Anaesthesia. 2019; 74(3):373-379. DOI: 10.1111/anae.14569. View

5.
Wohlmuth C, Tulzer G, Arzt W, Gitter R, Wertaschnigg D . Maternal aspects of fetal cardiac intervention. Ultrasound Obstet Gynecol. 2014; 44(5):532-7. DOI: 10.1002/uog.13438. View